However, the peptides action on melanocytes-the cells that produce pigment-raises questions about possible skin cancer risk
However, the expected increase in the SAM/SAH ratio in response to B12 was not observed

Skin reactions may result from: Immune-mediated hypersensitivity to the active semaglutide molecule itself Reactions to pharmaceutical excipients , particularly phenol or other preservatives Local tissue irritation from the subcutaneous injection process Formation of anti-drug antibodies , though this occurs in fewer than 1% of patients according to the EMA European Public Assessment Report (EPAR) for Ozempic Factors that may potentially increase susceptibility to Ozempic skin reactions include: Previous allergic reactions to other GLP-1 receptor agonists (such as liraglutide or dulaglutide) History of atopic conditions although evidence specifically linking atopy to increased risk of semaglutide reactions is limited Multiple drug allergies or known hypersensitivity to injectable medications Improper injection technique , such as injecting too superficially or failing to rotate injection sites Concurrent skin conditions at the injection site To minimise injection site reactions, avoid injecting into areas of infection, lipodystrophy, scars or active dermatitis

Get an extra boost, with these recommended vitamins
Our network includes physicians, nurse practitioners, and other qualified medical professionals who have extensive experience with GLP-1 medications
These are advised against during pregnancy due to concerns about potential birth defects